Mulmit

Evommune, Inc.Evommune, Inc.

EVMN NYSE

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3113,000,000-81,071,000-68,870,000-11.22
2024-12-317,000,000-70,013,000-66,808,000-45.29

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-07-08Carver KyleChief Financial Officer1,000
2026-07-07KIRSCH ARTHUR S10,000
2026-06-22Patel Jeegar PravinkumarChief Scientific Officer1,488
2026-06-22Patel Jeegar PravinkumarChief Scientific Officer1,488
2026-06-22Patel Jeegar PravinkumarChief Scientific Officer1,488
2026-06-22Drew Janice SuzannChief of Dev. Operations3,839
2026-06-22Drew Janice SuzannChief of Dev. Operations16,161
2026-06-22Drew Janice SuzannChief of Dev. Operations20,000
2026-06-22Drew Janice SuzannChief of Dev. Operations3,839
2026-06-22Drew Janice SuzannChief of Dev. Operations16,161
2026-06-22Pena Luis C.President & CEO7,438
2026-06-02Cohen David E5,456

8-K events

FiledItems
2026-09-23Regulation FD disclosure · Financial statements and exhibits
2026-09-15Regulation FD disclosure · Financial statements and exhibits
2026-09-09Regulation FD disclosure · Other events · Financial statements and exhibits
2026-08-06Results of operations · Financial statements and exhibits
2026-07-30Regulation FD disclosure · Financial statements and exhibits
2026-06-29Regulation FD disclosure · Other events · Financial statements and exhibits
2026-06-02Submission of matters to a vote
2026-05-07Results of operations · Regulation FD disclosure
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.